IBC Life Sciences

"IBC's conference is a fusion of business and scientific models to leverage India and China capabilities for the benefit of global drug discovery". -C.B. Rao, Chief Mentor, Orchid Research Laboratories Ltd. "An excellent conference focusing on opportunities in India and China. Superb presentations and excellent opportunity for business networking and business development". Raj (SB) Rajur, Chairman & CEO, Creagen Biosciences, Inc. "Great avenue to bring together the buyer (pharma) and the seller (CRO). Generated good debate on pros and cons of work in India-China". Uday Szxena, CEO, Kareus Therapeutics

CROs and Pharmaceutical Firms Evaluate Capabilities in Asia and Collaboration Strategies You Need to Accelerate Drug Discovery and Development, including:

• Collaborative Discovery Programs and NME Pipelines that Boost R&D Productivity
• Leveraging Integrated Biology and Chemistry Services in China and India to Speed up Drug Discovery and Development
• Scientific and Technological Innovations to Alleviate Bottlenecks in the R&D Pipeline
• Partnering Models of Shared Risk and Reward for Higher Economic and Competitive Advantage
• Unraveling Regulatory Challenges and Protecting Intellectual Property in Asia to Enable Solid Infrastructure Growth
• Growing Capabilities of Academic Research Centers and Successfully Tapping Lucrative Therapeutic Area Research
• Realizing Potential Gaps and Deficiencies in Preclinical Sourcing, Inventory Resources and GLP Labs
• Licensing Trends and Co-Development Deals that Bring a Larger Amount of Drugs to Market More Efficiently